Glucose News and Research

RSS

Studies show AHA's Life's Simple 7 and Diabetes Shared Care Program reduce lifetime risk of heart failure

One in four middle-aged adults who survive to age 85 will develop heart failure, according to current estimates.

15 Sep 2015

Philips, Radboudumc introduce first diabetes prototype system

Royal Philips and Netherlands-based Radboud university medical center today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.

15 Sep 2015

A growing number of deaths attributed to avoidable risk factors

A wide range of avoidable risk factors to health – ranging from air pollution to poor diets to unsafe water – account for a growing number of deaths and a significant amount of disease burden, according to a new analysis of 79 risks in 188 countries.

11 Sep 2015

High blood pressure, smoking, and poor dietary habits are greatest risk factors for death

A huge international study of global causes of death has revealed that since 1990, there has been a profound change in risk factors for death.

11 Sep 2015

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.

11 Sep 2015

World expert panel recommends routine brain health screening for adults older than 70

A panel of world experts in aging convened at Saint Louis University recommended that everyone 70 and older should have their memory and reasoning ability evaluated annually by a doctor or health care provider.

10 Sep 2015

Researchers take new line of approach to combat Alzheimer's disease

Today, more than 5.1 million Americans live with Alzheimer's disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. Moreover, according to a 2012 survey, Americans fear Alzheimer's more than any other disease.

10 Sep 2015

New programme to prevent development of Type 2 diabetes achieves promising early results

A programme aimed at preventing the development of Type 2 diabetes in people at high risk of the disease has achieved "promising" early results, a study has found.

9 Sep 2015

Nearly half of U.S. adults have either diabetes or prediabetes, study finds

In 2011-2012, the estimated prevalence of diabetes among U.S. adults was 12 percent to 14 percent and the prevalence of prediabetes was 37 percent to 38 percent, indicating that about half of the U.S. adult population has either diabetes or prediabetes, according to a study in the September 8 issue of JAMA.

9 Sep 2015

New study reveals effect of diabetes drug on bone health, benefit of exercise in mice

Inside our bones there is fat. Diabetes increases the amount of this marrow fat. And now a study from the UNC School of Medicine shows how some diabetes drugs substantially increase bone fat and thus the risk of bone fractures.

9 Sep 2015

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

A symposium on optimising insulin pump therapy, particularly focused on infusion set failures, will be held in advance of the 51st European Association for the Study of Diabetes Annual Meeting on 14th September 2015 in Stockholm.

7 Sep 2015

Inhibiting key protein involved in glucose production may help in treating type 2 diabetes

Some treatments for type 2 diabetes make the body more sensitive to insulin, the hormone that lowers blood sugar. But new research at Washington University School of Medicine in St. Louis suggests a different strategy: slowing the production of glucose in the liver.

4 Sep 2015

Gut bacteria play major role in diabetes, obesity depending on host’s genetic makeup

The trillions of bacteria in your digestive system play a major role in your metabolism, and they're linked to your risks of type 2 diabetes, obesity and the related conditions that make up "metabolic syndrome," which has become a global health epidemic.

4 Sep 2015

Mitochondrial Pyruvate Carrier could potentially be a new drug target to treat diabetes

High blood sugar is a defining characteristic of Type 2 diabetes and the cause of many of the condition's complications, including kidney failure, heart disease, and blindness. Most diabetes medications aim to maintain normal blood sugar (glucose) levels and prevent high blood sugar by controlling insulin.

3 Sep 2015

Treating cancer cells with quizartinib inhibits key metabolic pathway, activates macroautophagy

A study published in The Journal of Cell Biology describes a way to force cancer cells to destroy a key metabolic enzyme they need to survive.

1 Sep 2015

Resverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015

Resverlogix Corp. is pleased to announce that Dr. Norman Wong, chief scientific officer of Resverlogix Corp. presented new data at the European Society of Cardiology (ESC) Congress 2015 in a poster presentation titled: "RVX-208, an orally active BET inhibitor, lowers CVD risk by activities beyond raising ApoA-I/HDL."

31 Aug 2015

LabStyle Innovations closes $2.5 million funding round

LabStyle Innovations Corp., developer of the Dario™ Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million.

31 Aug 2015

PATHWAY 3 study: Half dose combination of common diuretics reduces blood pressure

The combination of two commonly used diuretics, each at half dose, can significantly reduce blood pressure without the side-effects caused by full doses of either alone, researchers from the PATHWAY 3 study have found.

31 Aug 2015

ELIXA trial results demonstrate cardiovascular safety of lixisenatide drug

In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial.

31 Aug 2015

Drinking coffee increases risk of cardiovascular events in young adults with mild hypertension

Coffee drinking is associated with increased risk of cardiovascular events (mainly heart attacks) in young adults (18-45) with mild hypertension, according to research presented at ESC Congress today by Dr Lucio Mos, a cardiologist at Hospital of San Daniele del Friuli in Udine, Italy.

29 Aug 2015

Glucose News and Research

Studies show AHA's Life's Simple 7 and Diabetes Shared Care Program reduce lifetime risk of heart failure

Philips, Radboudumc introduce first diabetes prototype system

A growing number of deaths attributed to avoidable risk factors

High blood pressure, smoking, and poor dietary habits are greatest risk factors for death

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

World expert panel recommends routine brain health screening for adults older than 70

Researchers take new line of approach to combat Alzheimer's disease

New programme to prevent development of Type 2 diabetes achieves promising early results

Nearly half of U.S. adults have either diabetes or prediabetes, study finds

New study reveals effect of diabetes drug on bone health, benefit of exercise in mice

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

Inhibiting key protein involved in glucose production may help in treating type 2 diabetes

Gut bacteria play major role in diabetes, obesity depending on host’s genetic makeup

Mitochondrial Pyruvate Carrier could potentially be a new drug target to treat diabetes

Treating cancer cells with quizartinib inhibits key metabolic pathway, activates macroautophagy

Resverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015

LabStyle Innovations closes $2.5 million funding round

PATHWAY 3 study: Half dose combination of common diuretics reduces blood pressure

ELIXA trial results demonstrate cardiovascular safety of lixisenatide drug

Drinking coffee increases risk of cardiovascular events in young adults with mild hypertension

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News